Cardiovascular Diabetology

Papers
(The H4-Index of Cardiovascular Diabetology is 67. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
The association between index-year, average, and variability of the triglyceride-glucose index with health outcomes: more than a decade of follow-up in Tehran lipid and glucose study570
Dysregulation of long non-coding RNA gene expression pathways in monocytes of type 2 diabetes patients with cardiovascular disease395
Correction to: Mortality and cardiovascular events in diabetes mellitus patients at dialysis initiation treated with glucagon-like peptide-1 receptor agonists263
Healthy longevity-associated protein improves cardiac function in murine models of cardiomyopathy with preserved ejection fraction255
Proteinuria and the risk of Incident atrial fibrillation according to glycemic stages: a nationwide population-based cohort study230
Differential prognostic burden of cardiovascular disease and lower-limb amputation on the risk of all-cause death in people with long-standing type 1 diabetes223
Type 2 diabetes worsens the outcome of ischemia/reperfusion in female STEMI patients and female db/db mice with HFpEF cardiometabolic phenotype200
SREBP1 deficiency aggravates vascular calcification via iASPP-triggered ferroptosis of vascular smooth muscle cells192
Pseudohypoxia caused by germline genetic alterations in the VHL gene is associated with increased diabetes and cardiovascular risk: a UK biobank study189
Correction: Association between triglyceride–glucose index and mortality in critically ill patients with atrial fibrillation: a retrospective cohort study176
Multi-modal characterisation of early-stage, subclinical cardiac deterioration in patients with type 2 diabetes160
Surgical treatment on infective endocarditis: impact of diabetes on mortality159
Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes159
Association between non-insulin-based insulin resistance indices and cardiovascular events in patients undergoing percutaneous coronary intervention: a retrospective study120
Investigating sex-specific associations of lipid traits with type 2 diabetes, glycemic traits and sex hormones using Mendelian randomization120
Long-term dual-trajectories of TyG and LAP and their association with cardiometabolic multimorbidity in midlife: the CARDIA study120
Association between triglyceride–glucose index trajectories and radiofrequency ablation outcomes in patients with stage 3D atrial fibrillation117
High triglyceride-glucose index and stress hyperglycemia ratio as predictors of adverse cardiac events in patients with coronary chronic total occlusion: a large-scale prospective cohort study117
The interplay of inflammation, exosomes and Ca2+ dynamics in diabetic cardiomyopathy115
Obesity-induced mesenteric PVAT remodelling is sexually dimorphic, but not driven by ovarian hormones114
Bone proteins are associated with cardiovascular risk according to the SCORE2-Diabetes algorithm113
The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease113
Comprehensive transcriptomics and metabolomics analyses reveal that hyperhomocysteinemia is a high risk factor for coronary artery disease in a chinese obese population aged 40–65: a prospective cross112
Longitudinal assessment of coronary plaque regression related to sodium–glucose cotransporter-2 inhibitor using coronary computed tomography angiography108
Association between triglyceride–glucose index and mortality in critically ill patients with atrial fibrillation: a retrospective cohort study107
Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes103
Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study103
Impact of remnant cholesterol on short-term and long-term prognosis in patients with prediabetes or diabetes undergoing coronary artery bypass grafting: a large-scale cohort study103
Fenofibrate to prevent amputation and reduce vascular complications in patients with diabetes: FENO-PREVENT98
Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus97
The association between triglyceride glucose-body mass index and all-cause mortality in critically ill patients with atrial fibrillation: a retrospective study from MIMIC-IV database97
Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy96
Combined associations of visceral adipose tissue and adherence to a Mediterranean lifestyle with T2D and diabetic microvascular complications among individuals with prediabetes93
Impact of T2DM on right ventricular systolic dysfunction and interventricular interactions in patients with essential hypertension: evaluation using CMR tissue tracking93
The effectiveness of sodium-glucose co-transporter 2 inhibitors on cardiorenal outcomes: an updated systematic review and meta-analysis91
Epigenetic crossroads in metabolic and cardiovascular health: the role of DNA methylation in type 2 diabetes and cardiovascular diseases91
In-hospital glycemic variability and all-cause mortality among patients hospitalized for acute heart failure90
Associations of combined polygenic risk score and glycemic status with atrial fibrillation, coronary artery disease and ischemic stroke90
Improving 10-year cardiovascular risk prediction in patients with type 2 diabetes with metabolomics89
The triglyceride-glucose index is associated with atherosclerosis in patients with symptomatic coronary artery disease, regardless of diabetes mellitus and hyperlipidaemia88
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness an88
The atherogenic index of plasma and carotid atherosclerosis in a community population: a population-based cohort study in China85
Association between abdominal obesity indices and risk of cardiovascular events in Chinese populations with type 2 diabetes: a prospective cohort study85
Association between the triglyceride glucose index and in-hospital and 1-year mortality in patients with chronic kidney disease and coronary artery disease in the intensive care unit85
Effect of dapagliflozin on the prognosis of patients with acute myocardial infarction undergoing percutaneous coronary intervention83
Nonlinear relationship between atherogenic index of plasma and the risk of prediabetes: a retrospective study based on Chinese adults83
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes82
Sex differences and sex steroids influence on the presentation and severity of cardiovascular autonomic neuropathy of patients with type 1 diabetes82
Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation79
Data-independent LC-MS/MS analysis of ME/CFS plasma reveals a dysregulated coagulation system, endothelial dysfunction, downregulation of complement machinery79
Impact of red cell distribution width and red cell distribution width/albumin ratio on all-cause mortality in patients with type 2 diabetes and foot ulcers: a retrospective cohort study79
Elevated urine albumin-to-creatinine ratio increases the risk of new-onset heart failure in patients with type 2 diabetes77
BMI-based obesity classification misses children and adolescents with raised cardiometabolic risk due to increased adiposity76
Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management75
Ethnicity should be included as a risk factor for coronary artery calcium score74
Predicting major adverse cardiac events in diabetes and chronic kidney disease: a machine learning study from the Silesia Diabetes-Heart Project73
The association between the triglyceride–glucose index and vulnerable plaques in patients with type 2 diabetes mellitus: insights from coronary computed tomography angiography72
Triglyceride-glucose index is associated with a higher risk of stroke in a hypertensive population72
Plasma metabolite profile of legume consumption and future risk of type 2 diabetes and cardiovascular disease71
Lower miR-21/ROS/HNE levels associate with lower glycemia after habit-intervention: DIAPASON study 1-year later71
MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics71
Risk factors for cardiovascular disease in patients with metabolic-associated fatty liver disease: a machine learning approach70
Multi-trajectories of triglyceride-glucose index and lifestyle with Cardiovascular Disease: a cohort study70
Temporal patterns of multi-morbidity in 570157 ischemic heart disease patients: a nationwide cohort study70
Advances in cardiac organoid research: implications for cardiovascular disease treatment68
Correction: Higher HbA1c variability is associated with increased arterial stiffness in individuals with type 1 diabetes67
Plasma lipidic fingerprint associated with type 2 diabetes in patients with coronary heart disease: CORDIOPREV study67
Correction to: Expression of the SARS‑CoV‑2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system67
Effects of exenatide on coronary stent’s endothelialization in subjects with type 2 diabetes: a randomized controlled trial. The Rebuild study67
0.18607592582703